Detalles de la búsqueda
1.
Dose-enhanced immunochemotherapy followed by first-line autologous peripheral blood stem cell transplantation for young patients with high-risk aggressive B-cell lymphoma: an efficacy and prognostic factor analysis / 中华血液学杂志
Chinese Journal of Hematology
; (12): 215-220, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-929560
2.
Cdc37 Expression in Multiple Myeloma and Its Role in Cell Proliferation / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 1522-1527, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-922289
3.
Clinical Analysis of Patients with MGUS, Primary Light Chain Amyloidosis, Multiple Myeloma or Multiple Myeloma with Concurrent Amyloidosis / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 812-818, 2021.
Artículo
en Zh
| WPRIM | ID: wpr-880152
4.
The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion / 中华血液学杂志
Chinese Journal of Hematology
; (12): 228-233, 2020.
Artículo
en Zh
| WPRIM | ID: wpr-1012174
5.
Clinical Analysis of B-CLPD with Cytopemia as the Predominant Characteristic / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 839-843, 2019.
Artículo
en Zh
| WPRIM | ID: wpr-771875
6.
Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation / 中华血液学杂志
Chinese Journal of Hematology
; (12): 496-500, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-1011794
7.
Clinical analysis of 24 patients of hairy cell leukemia treated by cladribine / 中华血液学杂志
Chinese Journal of Hematology
; (12): 491-495, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-1011793
8.
Role of minimal residual disease detection by multiparameter flow cytometry in newly diagnosed multiple myeloma: an analysis of 106 patients / 中华血液学杂志
Chinese Journal of Hematology
; (12): 376-381, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-1011767
9.
Role of miR137-MITF in Prognostic Analysis of Multiple Myeloma / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 1096-1099, 2016.
Artículo
en Zh
| WPRIM | ID: wpr-246810
10.
Clinical feature and efficacy of patients with multiple myeloma and renal impairment treated with bortezomib based chemotherapy / 中华血液学杂志
Chinese Journal of Hematology
; (12): 304-308, 2013.
Artículo
en Zh
| WPRIM | ID: wpr-235486
11.
Prognostic value of serum IL-6 in patients with multiple myeloma / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 1492-1495, 2013.
Artículo
en Zh
| WPRIM | ID: wpr-264989
12.
Clinical and laboratory features of T-cell prolymphocytic leukemia in China / 中华血液学杂志
Chinese Journal of Hematology
; (12): 839-843, 2013.
Artículo
en Zh
| WPRIM | ID: wpr-272103
13.
Expression of B7-H1 gene in leukemia cells and its clinical significance / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 541-544, 2012.
Artículo
en Zh
| WPRIM | ID: wpr-263354
14.
The significances of 13q14 deletion for development and prognosis of multiple myeloma / 中华血液学杂志
Chinese Journal of Hematology
; (12): 217-220, 2011.
Artículo
en Zh
| WPRIM | ID: wpr-251989
15.
Outcome of bortezomib plus chemotherapy with or without stem cell transplantation for treatment of multiple myeloma / 中华血液学杂志
Chinese Journal of Hematology
; (12): 397-400, 2008.
Artículo
en Zh
| WPRIM | ID: wpr-240005
16.
Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients / 中华血液学杂志
Chinese Journal of Hematology
; (12): 217-221, 2008.
Artículo
en Zh
| WPRIM | ID: wpr-262904
17.
The analysis of prognostic variables in 123 patients with multiple myeloma / 中华血液学杂志
Chinese Journal of Hematology
; (12): 330-334, 2007.
Artículo
en Zh
| WPRIM | ID: wpr-328353
18.
Long-term survival analysis in 170 cases of acute promyelocytic leukemia / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 437-441, 2006.
Artículo
en Zh
| WPRIM | ID: wpr-233573
Resultados
1 -
18
de 18
1
Próxima >
>>